Skip to main content
. 2017 May 2;64(11):1557–1563. doi: 10.1093/cid/cix198

Table 2.

All-Cause Mortality Through Day 42 and Overall Outcome at the End of Therapy

Mortality and Outcome Isavuconazole (n = 79) Voriconazole (n = 79) Total (N = 158) 95% CI P Value
All-cause mortality through day 42 16 (20%) 12 (15%) 28 (17.7%) −8.1% to 20.3% .5320
Successful overall response at EOT 26 (33%) 30 (38%) 56 (35.4%) −21.2% to 11.1% .6178

Abbreviations: CI, confidence interval; EOT, end of therapy.